UK - Pension funds worth an estimated £1.7trn have been contacted by members supporting a campaign to stop a pharmaceutical company blocking poor counties' access to affordable medicines.
FairPensions and Oxfam drew attention to Novartis taking legal action against the Indian government over drug patent protection in January. This response from members came after by FairPensions an...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
